comparemela.com

Latest Breaking News On - Oxford biomedica plc - Page 11 : comparemela.com

Investegate |Oxford Biomedica PLC Announcements | Oxford Biomedica PLC: Publication of Circular & Notice of GM

Investegate announcements from Oxford Biomedica PLC, Publication of Circular & Notice of GM

United statesNew zealandUnited kingdomSouth africaRepublic of south africaStuart paynterMatthew nealSatheesh nadarajahSohail akbarDavid wilsonMary jane elliottOxford biomedicaSophia bolhassanJock maxwell macdonaldClaes spangBoehringer ingelheim

Investegate |Oxford Biomedica PLC Announcements | Oxford Biomedica PLC: Admission of Firm Placing Shares

Investegate announcements from Oxford Biomedica PLC, Admission of Firm Placing Shares

United statesNew zealandUnited kingdomSouth africaCity ofRepublic of south africaSimon elliottStuart paynterMatthew nealSatheesh nadarajahSohail akbarDavid wilsonJulian oakleyMary jane elliottOxford biomedicaSophia bolhassan

Oxford Biomedica Says Sio Gene Intends To End AXO-Lenti-PD License Deal

LONDON (dpa-AFX) - British gene and cell therapy company Oxford Biomedica Plc (OXB), said that Sio Gene Therapies has informed that it intends to return the global rights for AXO-Lenti-PD, a gene

United kingdomCity ofOxford biomedicaPavan cheruvuOxford biomedica plcSio gene therapiesUnited kingdom based

Investegate |Oxford BioMedica plc Announcements | Oxford BioMedica plc: Oxford Biomedica announces update to agreement with Sio Gene Therapies

Investegate announcements from Oxford BioMedica plc, Oxford Biomedica announces update to agreement with Sio Gene Therapies

United kingdomRoch doliveuxMary jane elliott matthew nealStuart paynterOxford biomedicaSophia bolhassanBoehringer ingelheimBristol myers squibbConsilium strategic communicationsSio gene therapiesSiogene therapiesAxovant gene therapiesGene therapyChief financialJane elliottHomology medicine

Investegate |Oxford Biomedica PLC Announcements | Oxford Biomedica PLC: Market Share Purchase

Investegate announcements from Oxford Biomedica PLC, Market Share Purchase

United kingdomCity ofMatthew treagusOxford biomedicaNatalie walterLondon stock exchangeBoehringer ingelheimBristol myers squibbMarket shareChief information officerAbuse regulationPerson discharging managerial responsibilityStock exchangeMain marketSio gene therapiesOrchard therapeutics

vimarsana © 2020. All Rights Reserved.